Latest updates
- In the press Exonate’s principal scientist, Dr Jennifer Batson, to present at Pharmacology 2017
- In the press Wellcome – 10 ideas we fund that might surprise you. From eyeball injections to eye drops for sight loss
- In the press Exonate announces the formation of ophthalmology Clinical Advisory Board (“Exonate” or the “Company”)
- In the press Exonate is the ‘One to Watch’ in the Best Investment in Life Sciences
- In the press Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD)
- Company news Exonate closes successful funding round – to develop eye drops treatment for wet age-related macular degeneration (wet AMD)